The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Vineet Laboratories's current ratio for the quarter that ended in Dec. 2025 was 0.00.
Vineet Laboratories has a current ratio of 0.00. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Vineet Laboratories has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Vineet Laboratories's Current Ratio or its related term are showing as below:
NSE:VINEETLAB'
s Current Ratio Range Over the Past 10 Years
Min: 0.91 Med: 1.17 Max: 998.25
Current: 0.95
During the past 9 years, Vineet Laboratories's highest Current Ratio was 998.25. The lowest was 0.91. And the median was 1.17.
NSE:VINEETLAB's Current Ratio is ranked worse than 86.15% of 1610
companies
in the Chemicals industry
Industry Median: 1.89
vs NSE:VINEETLAB: 0.95
Vineet Laboratories (NSE:VINEETLAB) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Vineet Laboratories Current Ratio Related Terms
Vineet Laboratories Current Ratio Historical Data
* Premium members only.
The historical data trend for Vineet Laboratories's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Vineet Laboratories's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vineet Laboratories Current Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Vineet Laboratories's Current Ratio distribution charts can be found below:
* The bar in red indicates where Vineet Laboratories's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vineet Laboratories (NSE:VINEETLAB) has a Current Ratio of 0.00 as of Dec. 2025. Over the past decade, Vineet Laboratories' Current Ratio has ranged from 0.91 to 998.25. According to the industry distribution chart, Vineet Laboratories ranks #1387 out of 1610 companies in the Chemicals industry, placing it in the top 86.1%.
Is Vineet Laboratories' Current Ratio too high?
Vineet Laboratories' current Current Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 998.25. Based on the distribution chart, Vineet Laboratories ranks #1387 out of 1610 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Vineet Laboratories has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vineet Laboratories' Current Ratio compare to DOW?
According to the Chemicals industry distribution chart, Vineet Laboratories ranks #1387 out of 1610 companies for Current Ratio. This places Vineet Laboratories in the lower half of its industry. The industry median Current Ratio is 1.89. Historically, Vineet Laboratories' own Current Ratio has ranged from 0.91 to 998.25 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Chemicals company?
The median Current Ratio among Chemicals companies is 1.89, based on 1,610 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Current Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vineet Laboratories's current Current Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vineet Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.48, compared to a current price of ₹34.00 — trading 119.6% above its estimated fair value. The current Current Ratio is 0.00. Vineet Laboratories' overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current Current Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued.
The current stock price of ₹34.00 is trading 119.6% above its estimated GF Value™ of ₹15.48.
GuruFocus considers Vineet Laboratories to be Significantly Overvalued.
Key valuation signals for NSE:VINEETLAB:
Current Ratio: 0.00
GF Value™: ₹15.48 vs. price of ₹34.00 (119.6% above fair value)
No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.
38GF Score
Get the complete analysis for NSE:VINEETLAB
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VINEETLAB has been successfully added to your 
